Literature DB >> 12217628

Selective destruction of dopaminergic neurons by low concentrations of 6-OHDA and MPP+: protection by acetylsalicylic acid aspirin.

Emilce Carrasco1, Peter Werner.   

Abstract

We optimized a mesencephalic cell culture system to employ low concentrations of 6-hydroxydopamine (6-OHDA) and 1-methyl-4 phenylpyridinium (MPP+), neurotoxins known to trigger oxidative stress in dopaminergic cells. Both 6-OHDA and MPP(+) at 5 micro M reproducibly reduced the survival of dopaminergic neurons by 50-70% (p<0.02) without affecting the survival of the non-dopaminergic neuronal population. We found that 1mM of the non-steroidal anti-inflammatory drug (NSAID), acetylsalicylic acid (ASA), significantly (p<0.05) increased the survival of dopaminergic neurons exposed to either neurotoxin. The mechanisms underlying neuroprotection by ASA may be of therapeutic import in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217628     DOI: 10.1016/s1353-8020(02)00022-6

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  4 in total

1.  Prostaglandin receptor EP2 protects dopaminergic neurons against 6-OHDA-mediated low oxidative stress.

Authors:  Emilce Carrasco; Peter Werner; Diana Casper
Journal:  Neurosci Lett       Date:  2008-06-06       Impact factor: 3.046

2.  Cocaine induces alterations in mitochondrial membrane potential and dual cell cycle arrest in rat c6 astroglioma cells.

Authors:  Ramesh B Badisa; Selina F Darling-Reed; Carl B Goodman
Journal:  Neurochem Res       Date:  2009-09-16       Impact factor: 3.996

Review 3.  Proteomic approach to studying Parkinson's disease.

Authors:  Jing Zhang; David R Goodlett
Journal:  Mol Neurobiol       Date:  2004-06       Impact factor: 5.590

4.  Aspirin down Regulates Hepcidin by Inhibiting NF-κB and IL6/JAK2/STAT3 Pathways in BV-2 Microglial Cells Treated with Lipopolysaccharide.

Authors:  Wan-Ying Li; Fei-Mi Li; Yu-Fu Zhou; Zhong-Min Wen; Juan Ma; Ke Ya; Zhong-Ming Qian
Journal:  Int J Mol Sci       Date:  2016-12-16       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.